The global Digital Diabetes Management Market was valued at USD 13.45 billion in 2024, projected to reach USD 26.29 billion by 2032 with a CAGR of 7.42%. The US holds nearly 40% of the market due to high adoption of wearable glucose monitoring. Advancements in CGM technology are revolutionizing patient care and management.

Key drivers of the market include technological advancements, regulatory changes, and the increasing prevalence of diabetes. The market is expected to grow as medical device companies and digital health startups innovate to improve patient care and engagement. By 2030, the worldwide prevalence of diabetes is forecasted to exceed 700 million adults, driving the demand for digital tools.

In 2024, North America held the largest market share (~38%) due to advanced healthcare digitization and reimbursement policies. The Asia-Pacific market is expected to be the fastest-growing market, driven by the increasing prevalence of diabetes and a growing focus on chronic disease management. Recent developments include new product launches from Health2Sync, Dexcom, and Abbott.

The Digital Diabetes Management Market offers various products, including Smart Glucose Meters, CGM Systems, Insulin Pens, Insulin Pumps, and Apps. Wearable devices dominated the market in 2024, with hospitals accounting for 39.9% of end use. Market segmentation by region includes North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.

For detailed insights on the Digital Diabetes Management Market and a briefing with analysts, visit SNS Insider. Stay updated on market trends, competitive landscape, and company profiles. With a focus on providing accurate market data and consumer insights, SNS Insider aims to empower clients to make informed decisions in a changing market environment.

Read more at GlobeNewswire: Digital Diabetes Management Market to Reach USD 26.29